Methadone and naloxone in combination (Naldone) for the treatment of heroin addicts.
D000284:Administration, Oral; D000818:Animals; D001682:Biological Availability; D004304:Dosage Forms; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D000882:Haplorhini; D006556:Heroin Dependence / Q000188:drug therapy*; D006801:Humans; D007275:Injections, Intravenous; D008691:Methadone / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D009270:Naloxone / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D011680:Pupil / Q000187:drug effects; D051381:Rats; D013375:Substance Withdrawal Syndrome; D013997:Time Factors
D004304:Dosage Forms; D004338:Drug Combinations; D009270:Naloxone; D008691:Methadone